Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis

Objective A major challenge in multiple sclerosis (MS) research is the understanding of silent progression and Progressive MS. Using a novel method to accurately capture upper cervical cord area from legacy brain MRI scans we aimed to study the role of spinal cord and brain atrophy for silent progre...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Annals of neurology Ročník 91; číslo 2; s. 268 - 281
Hlavní autori:	Bischof, Antje, Papinutto, Nico, Keshavan, Anisha, Rajesh, Anand, Kirkish, Gina, Zhang, Xinheng, Mallott, Jacob M., Asteggiano, Carlo, Sacco, Simone, Gundel, Tristan J., Zhao, Chao, Stern, William A., Caverzasi, Eduardo, Zhou, Yifan, Gomez, Refujia, Ragan, Nicholas R., Santaniello, Adam, Zhu, Alyssa H., Juwono, Jeremy, Bevan, Carolyn J., Bove, Riley M., Crabtree, Elizabeth, Gelfand, Jeffrey M., Goodin, Douglas S., Graves, Jennifer S., Green, Ari J., Oksenberg, Jorge R., Waubant, Emmanuelle, Wilson, Michael R., Zamvil, Scott S., Cree, Bruce A. C., Hauser, Stephen L., Henry, Roland G.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Hoboken, USA John Wiley & Sons, Inc 01.02.2022 Wiley Subscription Services, Inc
Predmet:	Adult Atrophy Brain Brain - diagnostic imaging Brain - pathology Conversion Deceleration Disease Progression Female Foramen Magnum - diagnostic imaging Foramen Magnum - pathology Humans Magnetic Resonance Imaging Male Middle Aged Multiple sclerosis Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging Multiple Sclerosis, Relapsing-Remitting - pathology Predictive Value of Tests Prognosis Prospective Studies Spinal cord Spinal Cord - diagnostic imaging Spinal Cord - pathology
ISSN:	0364-5134, 1531-8249, 1531-8249
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Objective A major challenge in multiple sclerosis (MS) research is the understanding of silent progression and Progressive MS. Using a novel method to accurately capture upper cervical cord area from legacy brain MRI scans we aimed to study the role of spinal cord and brain atrophy for silent progression and conversion to secondary progressive disease (SPMS). Methods From a single‐center observational study, all RRMS (n = 360) and SPMS (n = 47) patients and 80 matched controls were evaluated. RRMS patient subsets who converted to SPMS (n = 54) or silently progressed (n = 159), respectively, during the 12‐year observation period were compared to clinically matched RRMS patients remaining RRMS (n = 54) or stable (n = 147), respectively. From brain MRI, we assessed the value of brain and spinal cord measures to predict silent progression and SPMS conversion. Results Patients who developed SPMS showed faster cord atrophy rates (−2.19%/yr) at least 4 years before conversion compared to their RRMS matches (−0.88%/yr, p < 0.001). Spinal cord atrophy rates decelerated after conversion (−1.63%/yr, p = 0.010) towards those of SPMS patients from study entry (−1.04%). Each 1% faster spinal cord atrophy rate was associated with 69% (p < 0.0001) and 53% (p < 0.0001) shorter time to silent progression and SPMS conversion, respectively. Interpretation Silent progression and conversion to secondary progressive disease are predominantly related to cervical cord atrophy. This atrophy is often present from the earliest disease stages and predicts the speed of silent progression and conversion to Progressive MS. Diagnosis of SPMS is rather a late recognition of this neurodegenerative process than a distinct disease phase. ANN NEUROL 2022;91:268–281
AbstractList	Objective A major challenge in multiple sclerosis (MS) research is the understanding of silent progression and Progressive MS. Using a novel method to accurately capture upper cervical cord area from legacy brain MRI scans we aimed to study the role of spinal cord and brain atrophy for silent progression and conversion to secondary progressive disease (SPMS). Methods From a single‐center observational study, all RRMS (n = 360) and SPMS (n = 47) patients and 80 matched controls were evaluated. RRMS patient subsets who converted to SPMS (n = 54) or silently progressed (n = 159), respectively, during the 12‐year observation period were compared to clinically matched RRMS patients remaining RRMS (n = 54) or stable (n = 147), respectively. From brain MRI, we assessed the value of brain and spinal cord measures to predict silent progression and SPMS conversion. Results Patients who developed SPMS showed faster cord atrophy rates (−2.19%/yr) at least 4 years before conversion compared to their RRMS matches (−0.88%/yr, p < 0.001). Spinal cord atrophy rates decelerated after conversion (−1.63%/yr, p = 0.010) towards those of SPMS patients from study entry (−1.04%). Each 1% faster spinal cord atrophy rate was associated with 69% (p < 0.0001) and 53% (p < 0.0001) shorter time to silent progression and SPMS conversion, respectively. Interpretation Silent progression and conversion to secondary progressive disease are predominantly related to cervical cord atrophy. This atrophy is often present from the earliest disease stages and predicts the speed of silent progression and conversion to Progressive MS. Diagnosis of SPMS is rather a late recognition of this neurodegenerative process than a distinct disease phase. ANN NEUROL 2022;91:268–281 ObjectiveA major challenge in multiple sclerosis (MS) research is the understanding of silent progression and Progressive MS. Using a novel method to accurately capture upper cervical cord area from legacy brain MRI scans we aimed to study the role of spinal cord and brain atrophy for silent progression and conversion to secondary progressive disease (SPMS).MethodsFrom a single‐center observational study, all RRMS (n = 360) and SPMS (n = 47) patients and 80 matched controls were evaluated. RRMS patient subsets who converted to SPMS (n = 54) or silently progressed (n = 159), respectively, during the 12‐year observation period were compared to clinically matched RRMS patients remaining RRMS (n = 54) or stable (n = 147), respectively. From brain MRI, we assessed the value of brain and spinal cord measures to predict silent progression and SPMS conversion.ResultsPatients who developed SPMS showed faster cord atrophy rates (−2.19%/yr) at least 4 years before conversion compared to their RRMS matches (−0.88%/yr, p < 0.001). Spinal cord atrophy rates decelerated after conversion (−1.63%/yr, p = 0.010) towards those of SPMS patients from study entry (−1.04%). Each 1% faster spinal cord atrophy rate was associated with 69% (p < 0.0001) and 53% (p < 0.0001) shorter time to silent progression and SPMS conversion, respectively.InterpretationSilent progression and conversion to secondary progressive disease are predominantly related to cervical cord atrophy. This atrophy is often present from the earliest disease stages and predicts the speed of silent progression and conversion to Progressive MS. Diagnosis of SPMS is rather a late recognition of this neurodegenerative process than a distinct disease phase. ANN NEUROL 2022;91:268–281 A major challenge in multiple sclerosis (MS) research is the understanding of silent progression and Progressive MS. Using a novel method to accurately capture upper cervical cord area from legacy brain MRI scans we aimed to study the role of spinal cord and brain atrophy for silent progression and conversion to secondary progressive disease (SPMS). From a single-center observational study, all RRMS (n = 360) and SPMS (n = 47) patients and 80 matched controls were evaluated. RRMS patient subsets who converted to SPMS (n = 54) or silently progressed (n = 159), respectively, during the 12-year observation period were compared to clinically matched RRMS patients remaining RRMS (n = 54) or stable (n = 147), respectively. From brain MRI, we assessed the value of brain and spinal cord measures to predict silent progression and SPMS conversion. Patients who developed SPMS showed faster cord atrophy rates (-2.19%/yr) at least 4 years before conversion compared to their RRMS matches (-0.88%/yr, p < 0.001). Spinal cord atrophy rates decelerated after conversion (-1.63%/yr, p = 0.010) towards those of SPMS patients from study entry (-1.04%). Each 1% faster spinal cord atrophy rate was associated with 69% (p < 0.0001) and 53% (p < 0.0001) shorter time to silent progression and SPMS conversion, respectively. Silent progression and conversion to secondary progressive disease are predominantly related to cervical cord atrophy. This atrophy is often present from the earliest disease stages and predicts the speed of silent progression and conversion to Progressive MS. Diagnosis of SPMS is rather a late recognition of this neurodegenerative process than a distinct disease phase. ANN NEUROL 2022;91:268-281. A major challenge in multiple sclerosis (MS) research is the understanding of silent progression and Progressive MS. Using a novel method to accurately capture upper cervical cord area from legacy brain MRI scans we aimed to study the role of spinal cord and brain atrophy for silent progression and conversion to secondary progressive disease (SPMS).OBJECTIVEA major challenge in multiple sclerosis (MS) research is the understanding of silent progression and Progressive MS. Using a novel method to accurately capture upper cervical cord area from legacy brain MRI scans we aimed to study the role of spinal cord and brain atrophy for silent progression and conversion to secondary progressive disease (SPMS).From a single-center observational study, all RRMS (n = 360) and SPMS (n = 47) patients and 80 matched controls were evaluated. RRMS patient subsets who converted to SPMS (n = 54) or silently progressed (n = 159), respectively, during the 12-year observation period were compared to clinically matched RRMS patients remaining RRMS (n = 54) or stable (n = 147), respectively. From brain MRI, we assessed the value of brain and spinal cord measures to predict silent progression and SPMS conversion.METHODSFrom a single-center observational study, all RRMS (n = 360) and SPMS (n = 47) patients and 80 matched controls were evaluated. RRMS patient subsets who converted to SPMS (n = 54) or silently progressed (n = 159), respectively, during the 12-year observation period were compared to clinically matched RRMS patients remaining RRMS (n = 54) or stable (n = 147), respectively. From brain MRI, we assessed the value of brain and spinal cord measures to predict silent progression and SPMS conversion.Patients who developed SPMS showed faster cord atrophy rates (-2.19%/yr) at least 4 years before conversion compared to their RRMS matches (-0.88%/yr, p < 0.001). Spinal cord atrophy rates decelerated after conversion (-1.63%/yr, p = 0.010) towards those of SPMS patients from study entry (-1.04%). Each 1% faster spinal cord atrophy rate was associated with 69% (p < 0.0001) and 53% (p < 0.0001) shorter time to silent progression and SPMS conversion, respectively.RESULTSPatients who developed SPMS showed faster cord atrophy rates (-2.19%/yr) at least 4 years before conversion compared to their RRMS matches (-0.88%/yr, p < 0.001). Spinal cord atrophy rates decelerated after conversion (-1.63%/yr, p = 0.010) towards those of SPMS patients from study entry (-1.04%). Each 1% faster spinal cord atrophy rate was associated with 69% (p < 0.0001) and 53% (p < 0.0001) shorter time to silent progression and SPMS conversion, respectively.Silent progression and conversion to secondary progressive disease are predominantly related to cervical cord atrophy. This atrophy is often present from the earliest disease stages and predicts the speed of silent progression and conversion to Progressive MS. Diagnosis of SPMS is rather a late recognition of this neurodegenerative process than a distinct disease phase. ANN NEUROL 2022;91:268-281.INTERPRETATIONSilent progression and conversion to secondary progressive disease are predominantly related to cervical cord atrophy. This atrophy is often present from the earliest disease stages and predicts the speed of silent progression and conversion to Progressive MS. Diagnosis of SPMS is rather a late recognition of this neurodegenerative process than a distinct disease phase. ANN NEUROL 2022;91:268-281.
Author	Bove, Riley M. Papinutto, Nico Sacco, Simone Green, Ari J. Caverzasi, Eduardo Juwono, Jeremy Ragan, Nicholas R. Graves, Jennifer S. Keshavan, Anisha Henry, Roland G. Zamvil, Scott S. Kirkish, Gina Crabtree, Elizabeth Stern, William A. Cree, Bruce A. C. Rajesh, Anand Gomez, Refujia Mallott, Jacob M. Gundel, Tristan J. Wilson, Michael R. Zhao, Chao Hauser, Stephen L. Bevan, Carolyn J. Zhu, Alyssa H. Zhou, Yifan Waubant, Emmanuelle Goodin, Douglas S. Gelfand, Jeffrey M. Asteggiano, Carlo Santaniello, Adam Zhang, Xinheng Oksenberg, Jorge R. Bischof, Antje
AuthorAffiliation	Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA
AuthorAffiliation_xml	– name: Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA
Author_xml	– sequence: 1 givenname: Antje orcidid: 0000-0003-3862-5738 surname: Bischof fullname: Bischof, Antje organization: University Hospital Münster, Albert‐Schweitzer‐Campus 1 – sequence: 2 givenname: Nico surname: Papinutto fullname: Papinutto, Nico organization: University of California – sequence: 3 givenname: Anisha surname: Keshavan fullname: Keshavan, Anisha organization: University of California – sequence: 4 givenname: Anand surname: Rajesh fullname: Rajesh, Anand organization: University of California – sequence: 5 givenname: Gina surname: Kirkish fullname: Kirkish, Gina organization: University of California – sequence: 6 givenname: Xinheng surname: Zhang fullname: Zhang, Xinheng organization: University of California – sequence: 7 givenname: Jacob M. orcidid: 0000-0001-7309-3605 surname: Mallott fullname: Mallott, Jacob M. organization: University of California – sequence: 8 givenname: Carlo surname: Asteggiano fullname: Asteggiano, Carlo organization: University of California – sequence: 9 givenname: Simone surname: Sacco fullname: Sacco, Simone organization: University of California – sequence: 10 givenname: Tristan J. surname: Gundel fullname: Gundel, Tristan J. organization: University of California – sequence: 11 givenname: Chao surname: Zhao fullname: Zhao, Chao organization: University of California – sequence: 12 givenname: William A. surname: Stern fullname: Stern, William A. organization: University of California – sequence: 13 givenname: Eduardo orcidid: 0000-0002-0350-0460 surname: Caverzasi fullname: Caverzasi, Eduardo organization: University of California – sequence: 14 givenname: Yifan surname: Zhou fullname: Zhou, Yifan organization: University of California – sequence: 15 givenname: Refujia surname: Gomez fullname: Gomez, Refujia organization: University of California – sequence: 16 givenname: Nicholas R. surname: Ragan fullname: Ragan, Nicholas R. organization: University of California – sequence: 17 givenname: Adam surname: Santaniello fullname: Santaniello, Adam organization: University of California – sequence: 18 givenname: Alyssa H. surname: Zhu fullname: Zhu, Alyssa H. organization: University of California – sequence: 19 givenname: Jeremy surname: Juwono fullname: Juwono, Jeremy organization: University of California – sequence: 20 givenname: Carolyn J. surname: Bevan fullname: Bevan, Carolyn J. organization: University of California – sequence: 21 givenname: Riley M. surname: Bove fullname: Bove, Riley M. organization: University of California – sequence: 22 givenname: Elizabeth surname: Crabtree fullname: Crabtree, Elizabeth organization: University of California – sequence: 23 givenname: Jeffrey M. surname: Gelfand fullname: Gelfand, Jeffrey M. organization: University of California – sequence: 24 givenname: Douglas S. surname: Goodin fullname: Goodin, Douglas S. organization: University of California – sequence: 25 givenname: Jennifer S. orcidid: 0000-0003-1539-1940 surname: Graves fullname: Graves, Jennifer S. organization: University of California – sequence: 26 givenname: Ari J. surname: Green fullname: Green, Ari J. organization: University of California – sequence: 27 givenname: Jorge R. surname: Oksenberg fullname: Oksenberg, Jorge R. organization: University of California – sequence: 28 givenname: Emmanuelle orcidid: 0000-0001-5188-0157 surname: Waubant fullname: Waubant, Emmanuelle organization: University of California – sequence: 29 givenname: Michael R. surname: Wilson fullname: Wilson, Michael R. organization: University of California – sequence: 30 givenname: Scott S. orcidid: 0000-0003-2720-9915 surname: Zamvil fullname: Zamvil, Scott S. organization: University of California – sequence: 32 givenname: Bruce A. C. orcidid: 0000-0001-7689-2533 surname: Cree fullname: Cree, Bruce A. C. organization: University of California – sequence: 33 givenname: Stephen L. orcidid: 0000-0002-4932-4001 surname: Hauser fullname: Hauser, Stephen L. organization: University of California – sequence: 34 givenname: Roland G. surname: Henry fullname: Henry, Roland G. email: roland.henry@ucsf.edu organization: University of California
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/34878197$$D View this record in MEDLINE/PubMed
BookMark	eNp90UtLxDAQB_Agiq6Pg19ACl70UJ2kTZMel_UJvvBxLtl0opFsU5NW2W9vddWDoKeZw28GZv7rZLnxDRKyTeGAArBD1agDVjBJl8iI8oymkuXlMhlBVuQpp1m-RtZjfAaAsqCwStayXApJSzEiN3etbZRLJj7UybgLvn2aJzcBa6u7ODT-MWCM9hWTIxtRRUxsk9yiU220zWNy2bvOtg6TO-0w-GjjJlkxykXc-qob5OHk-H5yll5cn55PxhepznlOU-RgCgbIeTmVpq5NrY3UTPBSYyGBcmA5hUKDENwoqlFLYwquhKgln-Z1tkH2Fnvb4F96jF01s1Gjc6pB38eKFSAplEJmA939RZ99H4arPxTLGAgJYlA7X6qfzrCu2mBnKsyr718NYH8B9HBoDGh-CIXqI4dqyKH6zGGwh7-stp3qrG-6oKz7b-LNOpz_vboaX40XE-9bz5ez
CitedBy_id	crossref_primary_10_1007_s00062_023_01376_x crossref_primary_10_1016_j_msard_2024_105745 crossref_primary_10_1177_13524585231174781 crossref_primary_10_1007_s40263_024_01132_w crossref_primary_10_1177_17562864241229325 crossref_primary_10_1186_s40478_022_01391_y crossref_primary_10_1016_j_jns_2024_123356 crossref_primary_10_1016_j_msard_2023_105420 crossref_primary_10_1016_j_cct_2022_106941 crossref_primary_10_1111_ene_16583 crossref_primary_10_1016_j_nicl_2022_102985 crossref_primary_10_1016_j_nicl_2022_103244 crossref_primary_10_1212_NXI_0000000000200388 crossref_primary_10_1136_jnnp_2022_329333 crossref_primary_10_1177_13524585221143726 crossref_primary_10_1007_s00415_024_12514_x crossref_primary_10_1016_j_ncl_2023_06_008 crossref_primary_10_1136_jnnp_2022_329854 crossref_primary_10_1161_STROKEAHA_123_044666 crossref_primary_10_1016_j_msard_2022_104250 crossref_primary_10_1371_journal_pone_0312421 crossref_primary_10_1177_13524585251345317 crossref_primary_10_1016_j_msard_2025_106590 crossref_primary_10_1002_eji_202250228 crossref_primary_10_3389_fnmol_2023_1193636 crossref_primary_10_1016_j_msard_2022_103790 crossref_primary_10_3389_fneur_2022_1011579 crossref_primary_10_1093_braincomms_fcaf280 crossref_primary_10_1002_ana_26913 crossref_primary_10_1016_j_msard_2025_106567 crossref_primary_10_1007_s00415_025_13205_x crossref_primary_10_1016_j_autrev_2023_103480 crossref_primary_10_1080_1028415X_2022_2128010 crossref_primary_10_3390_ijms232314993 crossref_primary_10_1186_s12916_025_04366_7 crossref_primary_10_1097_WCO_0000000000001262 crossref_primary_10_1371_journal_pone_0300415 crossref_primary_10_1002_wsbm_1583 crossref_primary_10_3390_ijms24054375 crossref_primary_10_1002_ana_27298 crossref_primary_10_1148_ryai_240005 crossref_primary_10_1016_j_jns_2023_122846 crossref_primary_10_1016_S1474_4422_24_00027_9 crossref_primary_10_1155_2022_4928096 crossref_primary_10_1093_braincomms_fcaf243 crossref_primary_10_2174_0118715303325979241206115417 crossref_primary_10_3390_jcm14124114 crossref_primary_10_1038_s41591_025_03901_6 crossref_primary_10_3390_diagnostics14111120 crossref_primary_10_1080_14737175_2025_2506462 crossref_primary_10_1212_WNL_0000000000207768 crossref_primary_10_1016_j_ebiom_2025_105921 crossref_primary_10_1177_13524585241311441 crossref_primary_10_3390_app14135626 crossref_primary_10_1002_jmri_28625 crossref_primary_10_1080_14737175_2024_2398484 crossref_primary_10_3389_fimmu_2025_1543649 crossref_primary_10_1177_11795735241249693 crossref_primary_10_1186_s12883_022_02778_z crossref_primary_10_1007_s00415_025_12979_4 crossref_primary_10_1016_j_lanepe_2024_100977 crossref_primary_10_1093_brain_awac092 crossref_primary_10_1016_j_msard_2024_106248 crossref_primary_10_1212_WNL_0000000000207936 crossref_primary_10_1002_acn3_52187 crossref_primary_10_1371_journal_pone_0287463 crossref_primary_10_3389_fnimg_2025_1599966 crossref_primary_10_3389_fimmu_2024_1446748 crossref_primary_10_1002_ana_27270 crossref_primary_10_1053_j_sult_2023_03_017 crossref_primary_10_1177_13524585231196786 crossref_primary_10_1002_ana_26340 crossref_primary_10_1097_WCO_0000000000001369
Cites_doi	10.1186/s12880-016-0158-4 10.1002/mrm.26776 10.1136/jnnp.2005.068338 10.1002/ana.25463 10.1016/j.media.2007.06.004 10.1016/j.nicl.2017.11.002 10.1136/jnnp-2013-305298 10.1016/S1474-4422(18)30460-5 10.1111/bpa.12516 10.3174/ajnr.A2459 10.1016/j.neuroimage.2016.03.051 10.1136/jnnp.2007.134825 10.1038/srep36151 10.1038/s41582-020-0314-x 10.1002/ana.24241 10.1002/bimj.201700067 10.1111/jon.12553 10.1016/j.jcm.2016.02.012 10.1093/brain/awh721 10.1212/WNL.0000000000005853 10.1006/nimg.2002.1040 10.1093/brain/awab033 10.1111/ene.15098 10.1002/ana.24747 10.1016/S0166-4328(01)00297-2 10.1002/ana.25150 10.1001/archneurol.65.8.noc80042 10.1056/NEJMoa0909494 10.1016/S0140-6736(02)12023-X 10.1016/j.neuroimage.2011.02.046 10.1007/s10072-009-0161-4 10.1016/j.msard.2014.11.004 10.1212/WNL.33.11.1444 10.1016/S1474-4422(21)00095-8 10.1093/brain/aww173 10.1016/j.neuroimage.2009.12.121 10.1371/journal.pone.0115551 10.1038/s41467-021-22265-2 10.1136/jnnp-2014-308021 10.14260/jemds/2015/2342 10.1007/s00415-015-7754-z 10.1186/2193-1801-2-222 10.3389/fneur.2017.00433 10.1016/j.nicl.2019.101962 10.1212/NXI.0000000000000616 10.1007/s00415-017-8537-5 10.1002/ana.25145 10.1111/jon.12666 10.1002/jmri.24819 10.1016/j.neuroimage.2012.02.084
ContentType	Journal Article
Copyright	2021 The Authors. published by Wiley Periodicals LLC on behalf of American Neurological Association. 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. 2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml	– notice: 2021 The Authors. published by Wiley Periodicals LLC on behalf of American Neurological Association. – notice: 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. – notice: 2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
CorporateAuthor	University of California, San Francisco MS‐EPIC Team University of California, San Francisco MS-EPIC Team
CorporateAuthor_xml	– name: University of California, San Francisco MS‐EPIC Team – name: University of California, San Francisco MS-EPIC Team
DBID	24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7U7 C1K K9. 7X8
DOI	10.1002/ana.26281
DatabaseName	Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Toxicology Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic
DatabaseTitleList	ProQuest Health & Medical Complete (Alumni) MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1531-8249
EndPage	281
ExternalDocumentID	34878197 10_1002_ana_26281 ANA26281
Genre	article Research Support, Non-U.S. Gov't Journal Article Observational Study Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: National Institute of Neurological Diseases and Stroke funderid: K23 NS048869; R35NS111644; RO1NS26799 – fundername: NINDS NIH HHS grantid: R35 NS111644 – fundername: National Institute of Neurological Diseases and Stroke grantid: RO1NS26799 – fundername: National Institute of Neurological Diseases and Stroke grantid: R35NS111644 – fundername: NINDS NIH HHS grantid: R01 NS026799 – fundername: NINDS NIH HHS grantid: K23 NS048869
GroupedDBID	--- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1CY 1L6 1OB 1OC 1ZS 23M 24P 2QL 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 6J9 6P2 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEJM AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AAQQT AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABIVO ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBMB ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACRZS ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFAZI AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE AJJEV ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRMAN DRSTM EBS EJD EMOBN F00 F01 F04 F5P F8P FEDTE FUBAC FYBCS G-S G.N GNP GODZA GOZPB GRPMH H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M J5H JPC KBYEO KD1 KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LXL LXN LXY LYRES M6M MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ NNB O66 O9- OHT OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.- Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWD RWI RX1 SAMSI SJN SUPJJ TEORI UB1 V2E V8K V9Y VH1 W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 XJT XPP XSW XV2 YOC YQJ ZGI ZRF ZRR ZXP ZZTAW ~IA ~WT ~X8 AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7TK 7U7 C1K K9. 7X8
ID	FETCH-LOGICAL-c4541-e50f620e559b8fddfdcf8c2759ce68015024106c0775fa1cec8ff65a77d85b4d3
IEDL.DBID	24P
ISICitedReferencesCount	89
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000737912300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0364-5134 1531-8249
IngestDate	Sun Nov 09 11:26:35 EST 2025 Thu Dec 04 04:14:40 EST 2025 Wed Feb 19 02:23:54 EST 2025 Sat Nov 29 03:41:32 EST 2025 Tue Nov 18 21:08:13 EST 2025 Wed Jan 22 16:26:22 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	2
Language	English
License	Attribution-NonCommercial-NoDerivs 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4541-e50f620e559b8fddfdcf8c2759ce68015024106c0775fa1cec8ff65a77d85b4d3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3
ORCID	0000-0003-1539-1940 0000-0003-2720-9915 0000-0003-3862-5738 0000-0002-0350-0460 0000-0002-4932-4001 0000-0001-7689-2533 0000-0001-5188-0157 0000-0001-7309-3605
OpenAccessLink	https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fana.26281
PMID	34878197
PQID	2623207807
PQPubID	946345
PageCount	14
ParticipantIDs	proquest_miscellaneous_2608109783 proquest_journals_2623207807 pubmed_primary_34878197 crossref_primary_10_1002_ana_26281 crossref_citationtrail_10_1002_ana_26281 wiley_primary_10_1002_ana_26281_ANA26281
PublicationCentury	2000
PublicationDate	February 2022
PublicationDateYYYYMMDD	2022-02-01
PublicationDate_xml	– month: 02 year: 2022 text: February 2022
PublicationDecade	2020
PublicationPlace	Hoboken, USA
PublicationPlace_xml	– name: Hoboken, USA – name: United States – name: Minneapolis
PublicationTitle	Annals of neurology
PublicationTitleAlternate	Ann Neurol
PublicationYear	2022
Publisher	John Wiley & Sons, Inc Wiley Subscription Services, Inc
Publisher_xml	– name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc
References	2012; 61 2015; 262 2002; 17 2017; 8 2021; 20 2013; 2 2006; 77 2021; 28 2020; 16 2019; 18 2008; 79 2011; 56 2018; 83 2011; 16 1952; 21 2015; 86 2015; 42 2019; 24 2008; 65 2016; 80 2014; 9 2006; 129 2016; 01 2018; 79 2010; 31 2018; 28 2015; 4 2019; 6 2019; 30 2008; 12 2011; 32 2010; 362 2021; 144 2018; 60 2014; 85 2016; 16 2016; 15 2001; 125 1983; 33 2018; 17 2021; 12 2019; 85 2002; 360 2018; 91 2017 2016; 139 2017; 264 2016; 27 2014; 76 2010; 50 2018; 13 e_1_2_8_28_1 e_1_2_8_24_1 e_1_2_8_47_1 Schmidt P (e_1_2_8_27_1) 2017 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_5_1 e_1_2_8_7_1 e_1_2_8_9_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_41_1 e_1_2_8_17_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_32_1 e_1_2_8_55_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_53_1 e_1_2_8_51_1 e_1_2_8_30_1 e_1_2_8_29_1 e_1_2_8_25_1 e_1_2_8_46_1 e_1_2_8_48_1 e_1_2_8_2_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_8_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_23_1 e_1_2_8_44_1 e_1_2_8_40_1 e_1_2_8_39_1 e_1_2_8_14_1 e_1_2_8_35_1 Mc AD (e_1_2_8_3_1) 1952; 21 e_1_2_8_16_1 e_1_2_8_37_1 Ashtari F (e_1_2_8_18_1) 2011; 16 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_56_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_54_1 e_1_2_8_52_1 e_1_2_8_50_1 35233827 - Ann Neurol. 2022 May;91(5):735-736 35253269 - Ann Neurol. 2022 May;91(5):734-735
References_xml	– volume: 360 start-page: 2018 year: 2002 end-page: 2025 article-title: Mitoxantrone in progressive multiple sclerosis: a placebo‐controlled, double‐blind, randomised, multicentre trial publication-title: Lancet – volume: 56 start-page: 907 year: 2011 end-page: 922 article-title: A Bayesian model of shape and appearance for subcortical brain segmentation publication-title: Neuroimage – volume: 262 start-page: 1622 year: 2015 end-page: 1628 article-title: A longitudinal MRI study of cervical cord atrophy in multiple sclerosis publication-title: J Neurol – volume: 79 start-page: 1236 year: 2008 end-page: 1244 article-title: Regional grey matter atrophy in clinically isolated syndromes at presentation publication-title: J Neurol Neurosurg Psychiatry – volume: 9 year: 2014 article-title: Optimized brain extraction for pathological brains (optiBET) publication-title: PLoS One – volume: 18 start-page: 185 year: 2019 end-page: 197 article-title: Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders publication-title: Lancet Neurol – volume: 8 start-page: 433 year: 2017 article-title: The role of T1‐weighted derived measures of Neurodegeneration for assessing disability progression in multiple sclerosis publication-title: Front Neurol – volume: 33 start-page: 1444 year: 1983 end-page: 1452 article-title: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) publication-title: Neurology – volume: 50 start-page: 446 year: 2010 end-page: 455 article-title: Rapid semi‐automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis publication-title: Neuroimage – volume: 125 start-page: 279 year: 2001 end-page: 284 article-title: Controlling the false discovery rate in behavior genetics research publication-title: Behav Brain Res – volume: 28 start-page: 4153 year: 2021 end-page: 4166 article-title: CNS atrophy predicts future dynamics of disability progression in a real‐world multiple sclerosis cohort publication-title: Eur J Neurol – volume: 4 start-page: 52 year: 2015 end-page: 57 article-title: Cervical cord area measurement using volumetric brain magnetic resonance imaging in multiple sclerosis publication-title: Mult Scler Relat Disord – volume: 21 start-page: 135 year: 1952 end-page: 167 article-title: Some aspects of the natural history of disseminated sclerosis publication-title: Q J Med – volume: 79 start-page: 1595 year: 2018 end-page: 1601 article-title: Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T1 ‐weighted brain MRI acquisitions publication-title: Magn Reson Med – volume: 60 start-page: 431 year: 2018 end-page: 449 article-title: Variable selection ‐ a review and recommendations for the practicing statistician publication-title: Biom J – volume: 6 year: 2019 article-title: Contribution of normal aging to brain atrophy in MS publication-title: Neurol Neuroimmunol Neuroinflamm – volume: 01 start-page: 281 year: 2016 end-page: 294 article-title: Power estimation for non‐standardized multisite studies publication-title: Neuroimage – volume: 4 start-page: 16045 year: 2015 end-page: 16047 article-title: Sagittal diameter of foramen magnum in normal population: An mri study publication-title: Journal of Evolution of Medical and Dental Sciences – volume: 83 start-page: 210 year: 2018 end-page: 222 article-title: Deep gray matter volume loss drives disability worsening in multiple sclerosis publication-title: Ann Neurol – volume: 61 start-page: 1402 year: 2012 end-page: 1418 article-title: Within‐subject template estimation for unbiased longitudinal image analysis publication-title: Neuroimage – volume: 80 start-page: 499 year: 2016 end-page: 510 article-title: Long‐term evolution of multiple sclerosis disability in the treatment era publication-title: Ann Neurol – volume: 77 start-page: 51 year: 2006 end-page: 55 article-title: Increasing cord atrophy in early relapsing–remitting multiple sclerosis: a 3 year study publication-title: J Neurol Neurosurg Psychiatry – volume: 16 start-page: 457 year: 2011 end-page: 462 article-title: Effects of low dose methotrexate on relapsing–remitting multiple sclerosis in comparison to interferon beta‐1alpha: a randomized controlled trial publication-title: J Res Med Sci – volume: 91 start-page: e349 year: 2018 end-page: e358 article-title: Spinal cord volume loss: a marker of disease progression in multiple sclerosis publication-title: Neurology – volume: 15 start-page: 155 year: 2016 end-page: 163 article-title: A guideline of selecting and reporting intraclass correlation coefficients for reliability research publication-title: J Chiropr Med – volume: 76 start-page: 568 year: 2014 end-page: 580 article-title: Spinal cord gray matter atrophy correlates with multiple sclerosis disability publication-title: Ann Neurol – volume: 31 start-page: 29 year: 2010 end-page: 33 article-title: The first case history of multiple sclerosis: Augustus d'Este (1794–1848) publication-title: Neurol Sci. – volume: 17 start-page: 444 year: 2018 end-page: 451 article-title: Gray matter atrophy patterns in multiple sclerosis: a 10‐year source‐based morphometry study publication-title: Neuroimage Clin. – volume: 30 start-page: 110 year: 2019 end-page: 118 article-title: Intersubject variability and normalization strategies for spinal cord total cross‐sectional and gray matter areas publication-title: J Neuroimaging – volume: 16 start-page: 56 year: 2016 article-title: The effect of intramuscular interferon beta‐1a on spinal cord volume in relapsing–remitting multiple sclerosis publication-title: BMC Med Imaging – volume: 85 start-page: 279 year: 2014 end-page: 283 article-title: Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients publication-title: J Neurol Neurosurg Psychiatry – volume: 20 start-page: 653 year: 2021 end-page: 670 article-title: 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis publication-title: Lancet Neurol. – volume: 79 start-page: 1595 year: 2018 end-page: 1601 article-title: Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T1 ‐weighted brain MRI acquisitions publication-title: Magnetic Resonance in Medicine – volume: 86 start-page: 410 year: 2015 end-page: 418 article-title: Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis publication-title: J Neurol Neurosurg Psychiatry – volume: 32 start-page: 1138 year: 2011 end-page: 1142 article-title: A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis publication-title: AJNR Am J Neuroradiol. – volume: 85 start-page: 653 year: 2019 end-page: 666 article-title: Silent progression in disease activity‐free relapsing multiple sclerosis publication-title: Ann Neurol – volume: 2 start-page: 222 year: 2013 article-title: Principled missing data methods for researchers publication-title: Springerplus – volume: 264 start-page: 1402 year: 2017 end-page: 1412 article-title: Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2‐year follow‐up study publication-title: J Neurol – volume: 27 year: 2016 article-title: Fully automated grey and white matter spinal cord segmentation publication-title: Sci Rep – volume: 13 start-page: 556 year: 2018 end-page: 586 article-title: Spinal cord atrophy in multiple sclerosis: a systematic review and meta‐analysis publication-title: J Neuroimaging – volume: 65 start-page: 1044 year: 2008 end-page: 1051 article-title: Reduction of disease activity and disability with high‐dose cyclophosphamide in patients with aggressive multiple sclerosis publication-title: Arch Neurol. – volume: 129 start-page: 584 year: 2006 end-page: 594 article-title: The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease publication-title: Brain – volume: 362 start-page: 387 year: 2010 end-page: 401 article-title: A placebo‐controlled trial of oral fingolimod in relapsing multiple sclerosis publication-title: N Engl J Med – volume: 16 start-page: 171 year: 2020 end-page: 182 article-title: MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice publication-title: Nat Rev Neurol – volume: 42 start-page: 698 year: 2015 end-page: 708 article-title: 2D phase‐sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times publication-title: J Magn Reson Imaging – volume: 17 start-page: 479 year: 2002 end-page: 489 article-title: Accurate, robust, and automated longitudinal and cross‐sectional brain change analysis publication-title: Neuroimage – year: 2017 article-title: Bayesian inference for structured additive regression models for large‐scale problems with applications to medical imaging publication-title: Dissertation, LMU München: Fakultät für Mathematik, Informatik und Statistik – volume: 24 start-page: 101962 year: 2019 article-title: Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): high reproducibility and robustness to lesions, but large software and scanner effects publication-title: Neuroimage Clin. – volume: 83 start-page: 223 year: 2018 end-page: 234 article-title: Thalamic atrophy in multiple sclerosis: a magnetic resonance imaging marker of neurodegeneration throughout disease publication-title: Ann Neurol – volume: 28 start-page: 334 year: 2018 end-page: 348 article-title: Axonal loss in the multiple sclerosis spinal cord revisited publication-title: Brain Pathol – volume: 12 year: 2021 article-title: Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data publication-title: Nat Commun – volume: 139 start-page: 2395 year: 2016 end-page: 2405 article-title: Defining secondary progressive multiple sclerosis publication-title: Brain. – volume: 144 start-page: 1384 year: 2021 end-page: 1395 article-title: Cortical involvement determines impairment 30 years after a clinically isolated syndrome publication-title: Brain – volume: 12 start-page: 26 year: 2008 end-page: 41 article-title: Symmetric diffeomorphic image registration with cross‐correlation: evaluating automated labeling of elderly and neurodegenerative brain publication-title: Med Image Anal – ident: e_1_2_8_50_1 doi: 10.1186/s12880-016-0158-4 – ident: e_1_2_8_12_1 doi: 10.1002/mrm.26776 – ident: e_1_2_8_53_1 doi: 10.1136/jnnp.2005.068338 – ident: e_1_2_8_4_1 doi: 10.1002/ana.25463 – volume: 16 start-page: 457 year: 2011 ident: e_1_2_8_18_1 article-title: Effects of low dose methotrexate on relapsing–remitting multiple sclerosis in comparison to interferon beta‐1alpha: a randomized controlled trial publication-title: J Res Med Sci – ident: e_1_2_8_28_1 doi: 10.1016/j.media.2007.06.004 – ident: e_1_2_8_5_1 doi: 10.1016/j.nicl.2017.11.002 – ident: e_1_2_8_17_1 doi: 10.1136/jnnp-2013-305298 – ident: e_1_2_8_8_1 doi: 10.1016/S1474-4422(18)30460-5 – ident: e_1_2_8_43_1 doi: 10.1111/bpa.12516 – year: 2017 ident: e_1_2_8_27_1 article-title: Bayesian inference for structured additive regression models for large‐scale problems with applications to medical imaging publication-title: Dissertation, LMU München: Fakultät für Mathematik, Informatik und Statistik – ident: e_1_2_8_41_1 doi: 10.3174/ajnr.A2459 – ident: e_1_2_8_34_1 doi: 10.1016/j.neuroimage.2016.03.051 – ident: e_1_2_8_46_1 doi: 10.1136/jnnp.2007.134825 – ident: e_1_2_8_42_1 doi: 10.1038/srep36151 – ident: e_1_2_8_40_1 doi: 10.1038/s41582-020-0314-x – ident: e_1_2_8_21_1 doi: 10.1002/ana.24241 – ident: e_1_2_8_35_1 doi: 10.1002/bimj.201700067 – ident: e_1_2_8_49_1 doi: 10.1111/jon.12553 – ident: e_1_2_8_38_1 doi: 10.1016/j.jcm.2016.02.012 – ident: e_1_2_8_6_1 doi: 10.1093/brain/awh721 – ident: e_1_2_8_36_1 doi: 10.1212/WNL.0000000000005853 – ident: e_1_2_8_29_1 doi: 10.1006/nimg.2002.1040 – ident: e_1_2_8_48_1 doi: 10.1093/brain/awab033 – ident: e_1_2_8_45_1 doi: 10.1111/ene.15098 – ident: e_1_2_8_26_1 doi: 10.1002/mrm.26776 – ident: e_1_2_8_14_1 doi: 10.1002/ana.24747 – ident: e_1_2_8_37_1 doi: 10.1016/S0166-4328(01)00297-2 – ident: e_1_2_8_32_1 doi: 10.1002/ana.25150 – ident: e_1_2_8_20_1 doi: 10.1001/archneurol.65.8.noc80042 – ident: e_1_2_8_54_1 doi: 10.1056/NEJMoa0909494 – ident: e_1_2_8_56_1 doi: 10.1002/mrm.26776 – ident: e_1_2_8_19_1 doi: 10.1016/S0140-6736(02)12023-X – ident: e_1_2_8_31_1 doi: 10.1016/j.neuroimage.2011.02.046 – ident: e_1_2_8_2_1 doi: 10.1007/s10072-009-0161-4 – ident: e_1_2_8_11_1 doi: 10.1016/j.msard.2014.11.004 – ident: e_1_2_8_16_1 doi: 10.1212/WNL.33.11.1444 – ident: e_1_2_8_39_1 doi: 10.1016/S1474-4422(21)00095-8 – ident: e_1_2_8_15_1 doi: 10.1093/brain/aww173 – ident: e_1_2_8_22_1 doi: 10.1016/j.neuroimage.2009.12.121 – ident: e_1_2_8_30_1 doi: 10.1371/journal.pone.0115551 – ident: e_1_2_8_44_1 doi: 10.1038/s41467-021-22265-2 – volume: 21 start-page: 135 year: 1952 ident: e_1_2_8_3_1 article-title: Some aspects of the natural history of disseminated sclerosis publication-title: Q J Med – ident: e_1_2_8_10_1 doi: 10.1136/jnnp-2014-308021 – ident: e_1_2_8_55_1 doi: 10.14260/jemds/2015/2342 – ident: e_1_2_8_51_1 doi: 10.1007/s00415-015-7754-z – ident: e_1_2_8_25_1 doi: 10.1186/2193-1801-2-222 – ident: e_1_2_8_7_1 doi: 10.3389/fneur.2017.00433 – ident: e_1_2_8_24_1 doi: 10.1016/j.nicl.2019.101962 – ident: e_1_2_8_47_1 doi: 10.1212/NXI.0000000000000616 – ident: e_1_2_8_52_1 doi: 10.1007/s00415-017-8537-5 – ident: e_1_2_8_9_1 doi: 10.1002/ana.25145 – ident: e_1_2_8_13_1 doi: 10.1111/jon.12666 – ident: e_1_2_8_23_1 doi: 10.1002/jmri.24819 – ident: e_1_2_8_33_1 doi: 10.1016/j.neuroimage.2012.02.084 – reference: 35253269 - Ann Neurol. 2022 May;91(5):734-735 – reference: 35233827 - Ann Neurol. 2022 May;91(5):735-736
SSID	ssj0009610
Score	2.623461
Snippet	Objective A major challenge in multiple sclerosis (MS) research is the understanding of silent progression and Progressive MS. Using a novel method to... A major challenge in multiple sclerosis (MS) research is the understanding of silent progression and Progressive MS. Using a novel method to accurately capture... ObjectiveA major challenge in multiple sclerosis (MS) research is the understanding of silent progression and Progressive MS. Using a novel method to...
SourceID	proquest pubmed crossref wiley
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	268
SubjectTerms	Adult Atrophy Brain Brain - diagnostic imaging Brain - pathology Conversion Deceleration Disease Progression Female Foramen Magnum - diagnostic imaging Foramen Magnum - pathology Humans Magnetic Resonance Imaging Male Middle Aged Multiple sclerosis Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging Multiple Sclerosis, Relapsing-Remitting - pathology Predictive Value of Tests Prognosis Prospective Studies Spinal cord Spinal Cord - diagnostic imaging Spinal Cord - pathology
Title	Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis
URI	https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fana.26281 https://www.ncbi.nlm.nih.gov/pubmed/34878197 https://www.proquest.com/docview/2623207807 https://www.proquest.com/docview/2608109783
Volume	91
WOSCitedRecordID	wos000737912300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1531-8249 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009610 issn: 0364-5134 databaseCode: DRFUL dateStart: 19990101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB5CUkIufeTVbdOghBxycWJLtqylpyXp0kOyLHmxNyPrAQvBu6w3-f2Zkb0OoQ0UejECjSx7RiPNaDSfAE6kzp3J-iZSHn2TVKokUqJUkRBc98sM58yQ5fpwlY9GajLpj9fg5yoXpsGH6DbcSDPCfE0Krsv6_BU0VFf6jEtOadcbSSIU3dvA0_Er4q4MUAQUZ4uyRKQrWKGYn3dN3y5Gf1iYbw3WsOIMP_3Xt36Gj62hyQbNyPgCa67ahs3rNpS-A-PbOV2IxS7Q-2SD5WKG_GbjBdUvayzMgiOOcyG7bGI4bFoxOjo3p90Fdt0eRGS3-Hb8uWm9C_fDX3cXv6P2eoXIpFmaRC6LveSxQ5-iVN5ab41XhucoOScV7YTg6h5LQyB5XifGGeW9zHSeW5WVqRV7sF7NKvcVWBkbK4TOnCP0F2vQqEms7HtpvfGpsD04XfG5MC32OF2B8Vg0qMm8QA4VgUM9OO5I5w3gxt-IDlbCKlqdq6lGcLR44rwHR101aguFQHTlZk9EgyZQSF3pwX4j5K4Xgb4b2kfY-jTI8v3ui8FoEArf_p30O2xxypwIB74PYH25eHI_4IN5Xk7rxWEYuvjMJ-oQNi5vhvdXL1Ya8WM
linkProvider	Wiley-Blackwell
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS-QwEB9Ejztf9NRTVz0vig--1G2TNs2CL4uneLi7LKiHb6XNByxId9ld_fudSbsVOYUD3wpJmnYmk_nK_AJwIvPU6qSjA-XQN4mligIlChUIwfNOkeCe6atc__bSwUA9PHSGS3C-qIWp8CGagBtJht-vScApIN1-RQ3Ny_yMS0511ysxahla5TwevkLuSo9FQIm2IIlEvMAVCnm7GfpWG_1jYr61WL3KuVr_3Md-h7Xa1GTdam1swJItN-Frv06mb8HwdkJXYrEL9D9Zdz4dI8XZcErt8xk-jL0rjrsh-11lcdioZHR4bkLxBdavjyKyW3w7_t1o9gPury7vLq6D-oKFQMdJHAU2CZ3koUWvolDOGGe0U5qnyDsrFcVCUL-HUhNMnssjbbVyTiZ5mhqVFLER27Bcjku7C6wItREiT6wl_Bej0ayJjOw4aZx2sTAtOF0QOtM1-jhdgvGYVbjJPEMKZZ5CLThuuk4qyI33Oh0suJXVUjejFsHR5gnTFhw1zSgvlATJSzt-oj5oBPnilRbsVFxuZhHovaGFhKNPPTM_nj7rDrr-Ye__u_6Cb9d3_V7W-zO42YdVTnUU_vj3ASzPp0_2J3zRz_PRbHro1_ELfqvyxg
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dT9swED-hgtBe-NoG5dNMe-AlI7ETx5V4qSgV00pVjTHxFiX-kCqhtGoLfz93ThqEGNIk3iL5HCd3PvvO5_sdwHeZp1YnHR0oh75JLFUUKFGoQAied4oE10yf5fp3kA6H6v6-M1qBi2UuTIUP0Ry4kWb49ZoU3E6NO39BDc3L_AeXnPKuV2MqItOC1d7v_t3gBXRXejQCCrUFSSTiJbJQyM-bzq_3ozdG5mub1W86_c2Pfe4WbNTGJutWs2MbVmy5A-s3dTj9M4xup1QUi12iB8q6i9kEec5GM2pfzPFh4p1xXA9Zr4rjsHHJ6PrclE4Y2E19GZHd4tvx78bzL3DXv_pzeR3UJRYCHSdxFNgkdJKHFv2KQjljnNFOaZ6i9KxUdBqCO3woNQHluTzSVivnZJKnqVFJERvxFVrlpLR7wIpQGyHyxFpCgDEaDZvIyI6TxmkXC9OGsyWjM13jj1MZjIesQk7mGXIo8xxqw7eGdFqBbvyL6HAprazWuzm1CI5WT5i24bRpRo2hMEhe2skj0aAZ5NNX2rBbSbkZRaD_hjYS9j7zwnx_-Kw77PqH_f8nPYH1Ua-fDX4Ofx3AJ06JFP7-9yG0FrNHewRr-mkxns-O64n8DJEJ89w
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Spinal+Cord+Atrophy+Predicts+Progressive+Disease+in+Relapsing+Multiple+Sclerosis&rft.jtitle=Annals+of+neurology&rft.au=Bischof%2C+Antje&rft.au=Papinutto%2C+Nico&rft.au=Keshavan%2C+Anisha&rft.au=Anand%2C+Rajesh&rft.date=2022-02-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0364-5134&rft.eissn=1531-8249&rft.volume=91&rft.issue=2&rft.spage=268&rft.epage=281&rft_id=info:doi/10.1002%2Fana.26281&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0364-5134&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0364-5134&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0364-5134&client=summon